Results 31 to 40 of about 27,986 (235)

Obesity and airway responsiveness: Role of TNFR2 [PDF]

open access: yesPulmonary Pharmacology & Therapeutics, 2013
Obese mice exhibit innate airway hyperresponsiveness (AHR), a feature of asthma. Tumor necrosis factor alpha (TNFα) is implicated in the disease progression and chronic inflammatory status of both obesity and asthma. TNF acts via two TNF receptors, TNFR1 and TNFR2.
Alison S, Williams   +5 more
openaire   +2 more sources

The TNFα/TNFR2 axis mediates natural killer cell proliferation by promoting aerobic glycolysis

open access: yesCellular & Molecular Immunology, 2023
Natural killer (NK) cells are predominant innate lymphocytes that initiate the early immune response during infection. NK cells undergo a metabolic switch to fuel augmented proliferation and activation following infection.
A. Khan   +10 more
semanticscholar   +1 more source

Enhanced Microglia Activation and Glioma Tumor Progression by Inflammagen Priming in Mice with Tumor Necrosis Factor Receptor Type 2 Deficiency

open access: yesLife, 2021
Despite the fact that accumulation of microglia, the resident macrophages of the central nervous system (CNS) are the main feature of glioblastoma, the role of microglia in the progression of glioma is still arguable.
Chih-Kai Liao   +5 more
doaj   +1 more source

Blockade of TNF-α/TNFR2 signalling suppresses colorectal cancer and enhances the efficacy of anti-PD1 immunotherapy by decreasing CCR8+T regulatory cells

open access: yesJournal of Molecular Cell Biology, 2023
The enrichment of regulatory T cells (Tregs) in the tumour microenvironment (TME) has been recognized as one of the major factors in the initiation and development of resistance to immune checkpoint inhibitors.
Yi-Xian Guo   +16 more
semanticscholar   +1 more source

Microglial TNFR2 signaling regulates the inflammatory response after CNS injury in a sex-specific fashion

open access: yesBrain, behavior, and immunity, 2023
Microglia, the resident immune cells of the central nervous system (CNS), play a major role in damage progression and tissue remodeling after acute CNS injury, including ischemic stroke (IS) and spinal cord injury (SCI).
S. Raffaele   +20 more
semanticscholar   +1 more source

Co-modulation of TNFR1 and TNFR2 in an animal model of multiple sclerosis

open access: yesJournal of Neuroinflammation, 2023
Background Tumour necrosis factor (TNF) is a pleiotropic cytokine and master regulator of the immune system. It acts through two receptors resulting in often opposing biological effects, which may explain the lack of therapeutic potential obtained so far
Timon Fiedler   +8 more
semanticscholar   +1 more source

TNF RECEPTOR 2 AND DISEASE: Autoimmunity and Regenerative Medicine

open access: yesFrontiers in Immunology, 2013
The regulatory cytokine tumor necrosis factor (TNF) exerts its effects through two receptors: TNFR1 and TNFR2. Defects in TNFR2 signaling are evident in a variety of autoimmune diseases.
Denise Louise Faustman   +2 more
doaj   +1 more source

TNFR1 and TNFR2, Which Link NF-κB Activation, Drive Lung Cancer Progression, Cell Dedifferentiation, and Metastasis

open access: yesCancers, 2023
Simple Summary This review discusses new findings for the roles of TNFR1 and TNFR2 in the development of aggressive lung squamous cell carcinoma and lung adenocarcinoma by diverse signaling pathways in lung epithelial tumor cells and leukocytes ...
Gongping Shi, Yin-Ling Hu
semanticscholar   +1 more source

Sequential treatment with a TNFR2 agonist and a TNFR1 antagonist improves outcomes in a humanized mouse model for MS

open access: yesJournal of Neuroinflammation, 2023
TNF signaling is an essential regulator of cellular homeostasis. Through its two receptors TNFR1 and TNFR2, soluble versus membrane-bound TNF enable cell death or survival in a variety of cell types.
V. Pegoretti   +12 more
semanticscholar   +1 more source

Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome [PDF]

open access: yesLeukemia, 2018
Sézary syndrome (SS) is a rare form of cutaneous T-cell lymphoma often refractory to treatment. SS is defined as adenopathy, erythroderma with high numbers of atypical T cells. This offers an opportunity for new interventions and perhaps antibody-based therapeutic by virtue of its high expression of the TNFR2 oncogene on the tumor cells and on T ...
Torrey, H   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy